Operating Margin of Oncternal Therapeutics, Inc. from 31 Dec 2010 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Oncternal Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2010 to 30 Sep 2024.
  • Oncternal Therapeutics, Inc. Operating Margin for the quarter ending 30 Sep 2024 was -1664%, a 75% increase year-over-year.
  • Oncternal Therapeutics, Inc. annual Operating Margin for 2023 was -5314%, a 76% decline from 2022.
  • Oncternal Therapeutics, Inc. annual Operating Margin for 2022 was -3017%, a 315% decline from 2021.
  • Oncternal Therapeutics, Inc. annual Operating Margin for 2021 was -727%, a 40% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Oncternal Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2024 -1664% +5012% +75% 01 Jul 2024 30 Sep 2024
Q2 2024 -2041% +3172% +61% 01 Apr 2024 30 Jun 2024
Q1 2024 -3332% +1650% +33% 01 Jan 2024 31 Mar 2024
Q4 2023 -5314% -2297% -76% 01 Oct 2023 31 Dec 2023
Q3 2023 -6676% -4483% -204% 01 Jul 2023 30 Sep 2023
Q2 2023 -5212% -4123% -379% 01 Apr 2023 30 Jun 2023
Q1 2023 -4982% -4163% -508% 01 Jan 2023 31 Mar 2023
Q4 2022 -3017% -2290% -315% 01 Oct 2022 31 Dec 2022
Q3 2022 -2193% -1704% -348% 01 Jul 2022 30 Sep 2022
Q2 2022 -1089% -539% -98% 01 Apr 2022 30 Jun 2022
Q1 2022 -819% -290% -55% 01 Jan 2022 31 Mar 2022
Q4 2021 -727% -207% -40% 01 Oct 2021 31 Dec 2021
Q3 2021 -489% +259% +35% 01 Jul 2021 30 Sep 2021
Q2 2021 -549% +233% +30% 01 Apr 2021 30 Jun 2021
Q1 2021 -529% +873% +62% 01 Jan 2021 31 Mar 2021
Q4 2020 -520% +846% +62% 01 Oct 2020 31 Dec 2020
Q3 2020 -748% 01 Jul 2020 30 Sep 2020
Q2 2020 -782% 01 Apr 2020 30 Jun 2020
Q1 2020 -1402% 01 Jan 2020 31 Mar 2020
Q4 2019 -1365% 01 Oct 2019 31 Dec 2019
Q2 2012 -646% 01 Apr 2012 30 Jun 2012
Q1 2012 -631% 01 Jan 2012 31 Mar 2012
Q4 2011 -244% 01 Oct 2011 31 Dec 2011

Oncternal Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2023 -5314% -2297% -76% 01 Jan 2023 31 Dec 2023
2022 -3017% -2290% -315% 01 Jan 2022 31 Dec 2022
2021 -727% -207% -40% 01 Jan 2021 31 Dec 2021
2020 -520% +846% +62% 01 Jan 2020 31 Dec 2020
2019 -1365% -1064% -354% 01 Jan 2019 31 Dec 2019
2018 -301% 01 Jan 2018 31 Dec 2018
2011 -244% -268% -1078% 01 Jan 2011 31 Dec 2011
2010 25% 01 Jan 2010 31 Dec 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.